These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34852287)

  • 1. Mini-Review: Two Brothers in Crime - The Interplay of TRESK and TREK in Human Diseases.
    Huntemann N; Bittner S; Bock S; Meuth SG; Ruck T
    Neurosci Lett; 2022 Jan; 769():136376. PubMed ID: 34852287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRESK and TREK-2 two-pore-domain potassium channel subunits form functional heterodimers in primary somatosensory neurons.
    Lengyel M; Czirják G; Jacobson DA; Enyedi P
    J Biol Chem; 2020 Aug; 295(35):12408-12425. PubMed ID: 32641496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of K2P channels in sensory and motor neurons of the autonomic nervous system.
    Cadaveira-Mosquera A; Pérez M; Reboreda A; Rivas-Ramírez P; Fernández-Fernández D; Lamas JA
    J Mol Neurosci; 2012 Sep; 48(1):86-96. PubMed ID: 22544515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two-pore-domain potassium channels and molecular mechanisms underlying migraine].
    Royal P; Ávalos Prado P; Wdziekonski B; Sandoz G
    Biol Aujourdhui; 2019; 213(1-2):51-57. PubMed ID: 31274103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK.
    Royal P; Andres-Bilbe A; Ávalos Prado P; Verkest C; Wdziekonski B; Schaub S; Baron A; Lesage F; Gasull X; Levitz J; Sandoz G
    Neuron; 2019 Jan; 101(2):232-245.e6. PubMed ID: 30573346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of Functional Heterodimers by TREK-1 and TREK-2 Two-pore Domain Potassium Channel Subunits.
    Lengyel M; Czirják G; Enyedi P
    J Biol Chem; 2016 Jun; 291(26):13649-61. PubMed ID: 27129242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Special One: Architecture, Physiology and Pharmacology of the TRESK Channel.
    Schreiber JA; Düfer M; Seebohm G
    Cell Physiol Biochem; 2022 Nov; 56(6):663-684. PubMed ID: 36426390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore.
    Lengyel M; Czirják G; Enyedi P
    PLoS One; 2018; 13(5):e0197622. PubMed ID: 29763475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of analgesics and antidepressants on TREK-2 and TRESK currents.
    Park H; Kim EJ; Han J; Han J; Kang D
    Korean J Physiol Pharmacol; 2016 Jul; 20(4):379-85. PubMed ID: 27382354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc and mercuric ions distinguish TRESK from the other two-pore-domain K+ channels.
    Czirják G; Enyedi P
    Mol Pharmacol; 2006 Mar; 69(3):1024-32. PubMed ID: 16354767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacology of Two-Pore Domain Potassium Channels.
    Kamuene JM; Xu Y; Plant LD
    Handb Exp Pharmacol; 2021; 267():417-443. PubMed ID: 33880623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons.
    Kang D; Kim D
    Am J Physiol Cell Physiol; 2006 Jul; 291(1):C138-46. PubMed ID: 16495368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K
    Lengyel M; Erdélyi F; Pergel E; Bálint-Polonka Á; Dobolyi A; Bozsaki P; Dux M; Király K; Hegedűs T; Czirják G; Mátyus P; Enyedi P
    Mol Pharmacol; 2019 Jun; 95(6):652-660. PubMed ID: 30979812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels.
    Veale EL; Mathie A
    Br J Pharmacol; 2016 May; 173(10):1639-52. PubMed ID: 26914156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels.
    Al-Moubarak E; Veale EL; Mathie A
    Sci Rep; 2019 Aug; 9(1):12394. PubMed ID: 31455781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective and state-dependent activation of TRESK (K
    Lengyel M; Dobolyi A; Czirják G; Enyedi P
    Br J Pharmacol; 2017 Jul; 174(13):2102-2113. PubMed ID: 28419410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092.
    Walsh Y; Leach M; Veale EL; Mathie A
    Biochem Biophys Rep; 2021 Jul; 26():101021. PubMed ID: 34041373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
    Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
    ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stretch-activated two-pore potassium channels in human myometrium in pregnancy and labor.
    Buxton IL; Singer CA; Tichenor JN
    PLoS One; 2010 Aug; 5(8):e12372. PubMed ID: 20811500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-channel properties and pH sensitivity of two-pore domain K+ channels of the TALK family.
    Kang D; Kim D
    Biochem Biophys Res Commun; 2004 Mar; 315(4):836-44. PubMed ID: 14985088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.